Related Experiment Video

Updated: Aug 8, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Primary surgery revisited in very limited small cell lung cancer: does it have a role? A commentary

Morten Sorensen

    Lung Cancer (Amsterdam, Netherlands)
    |May 9, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
    08:26

    Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction

    Published on: March 24, 2023

    Related Experiment Videos

    Last Updated: Aug 8, 2026

    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
    11:17

    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

    Published on: February 27, 2026

    Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
    08:26

    Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction

    Published on: March 24, 2023

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study.

    Acta oncologica (Stockholm, Sweden)·2014

    Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme.

    Anticancer research·2013

    Sorafenib in advanced hepatocellular carcinoma: a nationwide retrospective study of efficacy and tolerability.

    TheScientificWorldJournal·2013

    Phase II open-label study of nintedanib in patients with recurrent glioblastoma multiforme.

    Journal of neuro-oncology·2012

    A phase I study of concurrent chemoradiotherapy and cetuximab for locally advanced esophageal cancer.

    Anticancer research·2012

    A phase II trial with bevacizumab and irinotecan for patients with primary brain tumors and progression after standard therapy.

    Acta oncologica (Stockholm, Sweden)·2012

    Standard targeted therapy implementation for driver alterations newly identified by comprehensive genomic profiling in clinically driver-negative advanced NSCLC.

    Lung cancer (Amsterdam, Netherlands)·2026

    Discordance in pleural mesothelioma response classification and modelling of impact on clinical trials.

    Lung cancer (Amsterdam, Netherlands)·2026

    Reassessing surgical resection in small cell lung cancer in the multimodal treatment era.

    Lung cancer (Amsterdam, Netherlands)·2026

    Characterization of the genomic and transcriptomic landscape of invasive non-mucinous lung adenocarcinoma based on IASLC grading.

    Lung cancer (Amsterdam, Netherlands)·2026

    Molecular concordance and clonal dynamics of KRAS mutations in lung adenocarcinoma across distinct clinical scenarios.

    Lung cancer (Amsterdam, Netherlands)·2026

    Long-term safety of first-line osimertinib plus platinum-pemetrexed in EGFR-mutated advanced NSCLC: FLAURA2.

    Lung cancer (Amsterdam, Netherlands)·2026

    Immune checkpoint inhibitors plus chemotherapy for early-stage or locally -advanced triple-negative breast cancer: a systematic review and Bayesian network meta-analysis of randomized trials.

    Frontiers in oncology·2026

    Interim efficacy and preliminary survival outcomes of polatuzumab vedotin in combination for diffuse large B-cell lymphoma: a retrospective real-world study.

    Frontiers in oncology·2026

    Pathological characteristics of cervical lymph node metastases in papillary thyroid carcinoma compared with lung adenocarcinoma.

    Frontiers in oncology·2026

    Contrast clearance analysis in post-operative brain metastases resection cavities: case series and literature review.

    Frontiers in oncology·2026

    Embrace Pain-A Randomized Controlled Trial of Online Acceptance and Commitment Therapy for Painful Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors.

    Psycho-oncology·2026

    Adding Treatment-Continuity Metrics to Opioid Toxicity Investigation: A Triangulation Hypothesis for Applied Toxicology.

    Journal of applied toxicology : JAT·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us